Statistics for UCT943, a next-generation plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of Malaria
Total visits
views | |
---|---|
UCT943, a next-generation plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of Malaria | 390 |
Total visits per month
views | |
---|---|
June 2024 | 4 |
July 2024 | 7 |
August 2024 | 14 |
September 2024 | 4 |
October 2024 | 1 |
November 2024 | 0 |
December 2024 | 0 |
File Visits
views | |
---|---|
Brunschwig_21563_2018.pdf | 114 |
Top country views
views | |
---|---|
United States | 123 |
South Africa | 86 |
United Kingdom | 41 |
Netherlands | 19 |
France | 16 |
Germany | 13 |
Vietnam | 11 |
Sweden | 10 |
Russia | 9 |
India | 8 |
China | 7 |
Ukraine | 7 |
Austria | 4 |
Belgium | 4 |
Japan | 3 |
Portugal | 2 |
Singapore | 2 |
A1 | 1 |
Australia | 1 |
European Union | 1 |
Greece | 1 |
Hong Kong SAR China | 1 |
Zimbabwe | 1 |
Top city views
views | |
---|---|
Southend | 31 |
Hanoi | 11 |
Johannesburg | 10 |
Jacksonville | 9 |
Pretoria | 8 |
Bengaluru | 7 |
Phoenix | 7 |
Ann Arbor | 6 |
Boardman | 5 |
Norwalk | 5 |
Woodbridge | 5 |
Cape Town | 4 |
Moscow | 4 |
Philadelphia | 4 |
Vienna | 4 |
Cambridge | 3 |
Denver | 3 |
Beijing | 2 |
Boydton | 2 |
Braga | 2 |
Chengdu | 2 |
Fairfield | 2 |
Houston | 2 |
Indianapolis | 2 |
Saint Petersburg | 2 |
San Jose | 2 |
Springs | 2 |
Ashburn | 1 |
Balashikha | 1 |
Boksburg | 1 |
Brisbane | 1 |
Central | 1 |
Centurion | 1 |
Chiba | 1 |
Council Bluffs | 1 |
Des Moines | 1 |
Encino | 1 |
Fullerton | 1 |
Germiston | 1 |
Hartbeespoort | 1 |
Hatfield | 1 |
Hebei | 1 |
Hyderabad | 1 |
Kempton Park | 1 |
Kunming | 1 |
Mentougou | 1 |
Moorpark | 1 |
Oakland | 1 |
Orange | 1 |
Piscataway | 1 |
Providence | 1 |
Roodepoort | 1 |
Rutland | 1 |
Singapore | 1 |
Stockholm | 1 |
Stuttgart | 1 |
Tokyo | 1 |
Wilmington | 1 |